Startups
Axio BioPharma accelerates monoclonal antibody development using AI-driven protein manufacturing. Cut timelines, reduce cost, and scale with confidence.
Overview
Location
United States
Total raised
$2.4M
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 15
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 3, 2026 | Axio BioPharma Secures $2.4 Million to Transform Biomanufacturing Data Flow | Axio BioPharma closed a $2.4 million pre-seed funding round. This vital capital empowers the firm to revolutionize biopharmaceutical manufacturing data connectivity. Its flagship Axio Lattice platform links pharma companies directly with th... |
| Nov 2, 2026 | Wisconsin VC funding for September 2026 | According to PitchBook, Wisconsin startups raised at least $5.6 million in disclosed funding in September 2026. Axio BioPharma develops a biomanufacturing data coordination platform that connects pharmaceutical companies with their manufact... |
| Oct 19, 2026 | Axio BioPharma and Elucidata Partner to Connect R&D Data with Biomanufacturing Workflows | Collaboration will explore how context established in R&D can remain connected and usable as biopharma programs move into process development and manufacturing MADISON, WI, UNITED STATES, October 19, 2026 /EINPresswire.com/ -- Axio BioP... |
| Sep 25, 2026 | Axio BioPharma Raises $2.4M in Pre Seed Funding | |
| Sep 21, 2026 | Axio BioPharma Raises $2.4 Million to Connect Manufacturing Data Across Companies | Funding will support initial Axio Lattice deployments connecting pharma with their manufacturing partners MADISON, WI, UNITED STATES, September 21, 2026 /EINPresswire.com/ -- Axio BioPharma, which helps pharma and their manufacturing partne... |
| Sep 1, 2026 | Axio BioPharma Selected for Plug and Play Lifetech Accelerator’s Third Cohort | Program participation will support industry engagement around Axio’s data infrastructure and execution capabilities for biologics development and manufacturing MADISON, WI, UNITED STATES, September 1, 2026 /EINPresswire.com/ -- Axio BioPhar... |
| Aug 10, 2026 | Axio BioPharma and The Bioforge Partner to Unlock Historical Biomanufacturing Data for AI-Driven Process Optimization | Partnership pairs Axio Lattice with BioOptima AI™ to unlock historical process knowledge while preserving data ownership MADISON, WI, UNITED STATES, August 10, 2026 /EINPresswire.com/ -- Axio BioPharma, a vendor-neutral data infrastructure ... |
| May 20, 2026 | Axio BioPharma Appoints Jim Wilson to Advisory Board | ZEA Biosciences CEO joins Axio to support strategic growth and biomanufacturing innovation MADISON, WI, UNITED STATES, May 20, 2026 /EINPresswire.com/ -- Axio BioPharma today announced the appointment of Jim Wilson, Chairman and CEO of ZEA ... |
| May 14, 2026 | Axio BioPharma Releases New Industry Report on the Future of AI-Enabled Biomanufacturing | New eBook provides a 2026 - 2029 outlook on AI in biomanufacturing and introduces an assessment framework for AI maturity MADISON, WI, UNITED STATES, May 14, 2026 /EINPresswire.com/ -- Axio BioPharma today announced the launch of its new in... |
Show more
Reviews 0
FAQ about Axio BioPharma
How much funding has Axio BioPharma raised?
Axio BioPharma has raised $2.4M in total across 1 funding round.
What has the press written about Axio BioPharma?
Parsers VC has collected 15 articles mentioning Axio BioPharma, among them “Axio BioPharma Secures $2.4 Million to Transform Biomanufacturing Data Flow” (Nov 3, 2026) and “Wisconsin VC funding for September 2026” (Nov 2, 2026).
Is Axio BioPharma still active?
Yes, Axio BioPharma is active; its latest activity on Parsers VC dates from Nov 5, 2026.